CLINICAL STUDIES
Safety and Efficacy of HAppyCross® in knee OA: Results of a Prospective Observational Study

Safety and Efficacy of HAppyCross® in knee OA: Results of a Prospective Observational Study

Safety and Efficacy of Single Intra-Articular Injection of a Cross-Linked Hyaluronic Acid/Mannitol Formulation [Happycross®] in knee Osteoarthritis Results of a Prospective Observational Study in Daily Practice Conditions. Monet M, Bozgan AM, Conrozier T. Ortho & Rheum Open Access 2017; 5(3): 555664. DOI: 10.19080/OROAJ.2017.05.555664. . This study has been conducted to assess in daily practice conditions,...
LABRHA at the OARSI Congress in Las Vegas in April 2017

LABRHA at the OARSI Congress in Las Vegas in April 2017

LABRHA participated at the OARSI 2017 World Congress which took place from the 27th to the 30th of April 2017 in Las Vegas. . 1) HAppyMini® in the Trapeziometacarpal joint: first results presented at the OARSI Congress . The abstract SAFETY AND EFFICACY OF A SINGLE INJECTION OF MANNITOL-MODIFIED CROSSLINKED HYALURONIC ACID (HAppyMini®) IN TRAPEZIOMETACARPIAL...
Obesity, radiological severity and lack of response of viscosupplementation in knee OA

Obesity, radiological severity and lack of response of viscosupplementation in knee OA

Viscosupplementation (VS) is still controversial. One of the key points is the lack of well-identified factors of response. The study « Obesity and radiological severity are associated with viscosupplementation failure in patients with knee osteoarthritis », published in Journal of Orthopaedic Research this month, has been designed to identify clinical and radiological factors associated with lack of...
Response to viscosupplementation with HAppyCross in hip OA: Discover the results in our published article

Response to viscosupplementation with HAppyCross in hip OA: Discover the results in our published article

Predictors of response to viscosupplementation in patients with hip osteoarthritis: results of a prospective, observational, multicentre, open-label, pilot study. Eymard et al. BMC Musculoskeletal Disorders (2017) 18:3. DOI 10.1186/s12891-016-1359-2. STUDY DESIGN Prospective, observational, multicentre, open-label study: 100 hip OA 59 men /41 women; mean age 62  (36-87) BMI 25,4 (17,9-41,8) 1 injection of HANOX-M-XL(HAppyCross®) under...
Discover our poster displayed at the ACR Congress in Washington DC in November 2016

Discover our poster displayed at the ACR Congress in Washington DC in November 2016

LABRHA participated at the ACR Congress in Washington DC, which took place from the 11th to the 16th of November 2016, and displayed a poster presenting the results of a study conducted to identify the clinical and radiological factors associated with a lack of a relevant response to viscosupplementation (VS) according to OMERACT-OARSI criteria after...